Literature DB >> 12496996

Primary cultures of prostate cells and their ability to activate carcinogens.

F L Martin1, K J Cole, G H Muir, G G Kooiman, J A Williams, R A Sherwood, P L Grover, D H Phillips.   

Abstract

Differences in the incidence of prostate cancer (CaP) amongst different migrant populations point to causative agents of dietary and/or environmental origin. Prostate tissues were obtained following transurethral resection of the prostate (TURP) or radical retropubic prostatectomy. After surgery, TURP-derived or tumour-adjacent tissue fragments were minced in warm PFMR-4A medium (37 degrees C) and suspensions pipetted into collagen-coated petri dishes. Non-adherent material was removed by washing with fresh medium after 12 h. Adhered cells subsequently reacted positively with monoclonal antibodies to prostate specific antigen (PSA). PSA was also detected in the medium. The genotoxicities of the chemical carcinogens 2-amino-1-methyl-6-phenylimidazo[4,5-b] pyridine (PhIP), its N-hydroxy metabolite (N-OH-PhIP) and benzo[a]pyrene (B[a]P) in adherent cell populations from different donors (n=8) were examined. Cells were treated in suspension for 30 min at 37 degrees C in the presence of the DNA repair inhibitors hydroxyurea (HU) and cytosine arabinoside (ara-C). DNA single-strand breaks were detected in cells by the alkaline single cell-gel electrophoresis ('Comet') assay and quantified by measuring comet tail length (CTL) in microm. All three carcinogens induced dose-related increases in CTLs (P<0.0001) in cells from four donors 24 h post-seeding. However, in cells from a further two donors the genotoxic effects of PhIP, N-OH-PhIP and B[a]P were much less apparent after 48 h than after 24 h in culture. After 96 h in culture, cells from these donors appeared to be resistant to the comet-forming activity of the compounds. However, B[a]P-DNA adducts were still measurable by (32)P-postlabelling for up to 14 days following a 24-h exposure to 50 microM B[a]P in adhered cells from another two donors. This study shows that primary cultures of cells derived from the prostate can activate members of two classes of chemical carcinogens. Further development may provide a robust model system in which to investigate the aetiology of CaP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12496996     DOI: 10.1038/sj.pcan.4500579

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  13 in total

Review 1.  Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis.

Authors:  Benjamin A Rybicki; Nora L Nock; Adnan T Savera; Deliang Tang; Andrew Rundle
Journal:  Cancer Lett       Date:  2005-09-09       Impact factor: 8.679

2.  Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model.

Authors:  Derek J Matoka; Veronica Yao; Diana S Harya; Jennifer L Gregg; Andria R Robinson; Laura J Niedernhofer; Anil V Parwani; Christoph Maier; Dean J Bacich
Journal:  Prostate       Date:  2011-12-27       Impact factor: 4.104

3.  Quantified gene expression levels for phase I/II metabolizing enzyme and estrogen receptor levels in benign prostate from cohorts designated as high-risk (UK) versus low-risk (India) for adenocarcinoma at this organ site: a preliminary study.

Authors:  Paras B Singh; Narasimhan Ragavan; Katherine M Ashton; Prabir Basu; Sayeed M Nadeem; Caroline M Nicholson; R K Gopala Krishna; Shyam S Matanhelia; Francis L Martin
Journal:  Asian J Androl       Date:  2009-11-23       Impact factor: 3.285

4.  No association between variant DNA repair genes and prostate cancer risk among men of African descent.

Authors:  Nicole A Lavender; Oyeyemi O Komolafe; Marnita Benford; Guy Brock; Jason H Moore; Tiva T Vancleave; J Christopher States; Rick A Kittles; La Creis R Kidd
Journal:  Prostate       Date:  2010-02-01       Impact factor: 4.104

5.  Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer.

Authors:  Stella Koutros; Sonja I Berndt; Rashmi Sinha; Xiaomei Ma; Nilanjan Chatterjee; Michael C R Alavanja; Tongzhang Zheng; Wen-Yi Huang; Richard B Hayes; Amanda J Cross
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

6.  2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-DNA adducts in benign prostate and subsequent risk for prostate cancer.

Authors:  Deliang Tang; Oleksandr N Kryvenko; Yun Wang; Sheri Trudeau; Andrew Rundle; Satoru Takahashi; Tomoyuki Shirai; Benjamin A Rybicki
Journal:  Int J Cancer       Date:  2013-03-09       Impact factor: 7.396

7.  Meat and meat mutagens and risk of prostate cancer in the Agricultural Health Study.

Authors:  Stella Koutros; Amanda J Cross; Dale P Sandler; Jane A Hoppin; Xiaomei Ma; Tongzhang Zheng; Michael C R Alavanja; Rashmi Sinha
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-01       Impact factor: 4.254

8.  Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression.

Authors:  Erin L Richman; Meir J Stampfer; Alan Paciorek; Jeanette M Broering; Peter R Carroll; June M Chan
Journal:  Am J Clin Nutr       Date:  2009-12-30       Impact factor: 7.045

Review 9.  Dietary Carcinogens and DNA Adducts in Prostate Cancer.

Authors:  Medjda Bellamri; Robert J Turesky
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

10.  Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.

Authors:  Kaarthik John; Narasimhan Ragavan; M Margaret Pratt; Paras B Singh; Salah Al-Buheissi; Shyam S Matanhelia; David H Phillips; Miriam C Poirier; Francis L Martin
Journal:  Prostate       Date:  2009-04-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.